GW&K Investment Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-740
| Closed | -$17K | – | 1017 |
|
|
2024
Q4 | $17K | Hold |
740
| – | – | ﹤0.01% | 661 |
|
|
2024
Q3 | $13K | Sell |
740
-532,409
| -100% | -$9.35M | ﹤0.01% | 705 |
|
|
2024
Q2 | $15.5M | Sell |
533,149
-166,366
| -24% | -$4.85M | 0.14% | 219 |
|
|
2024
Q1 | $24.8M | Buy |
699,515
+5,962
| +0.9% | +$211K | 0.22% | 173 |
|
|
2023
Q4 | $30.2M | Sell |
693,553
-64,611
| -9% | -$2.81M | 0.28% | 148 |
|
|
2023
Q3 | $29M | Buy |
758,164
+4,678
| +0.6% | +$179K | 0.29% | 141 |
|
|
2023
Q2 | $31M | Sell |
753,486
-17,774
| -2% | -$731K | 0.29% | 143 |
|
|
2023
Q1 | $44.3M | Buy |
771,260
+6,622
| +0.9% | +$380K | 0.43% | 98 |
|
|
2022
Q4 | $42.9M | Sell |
764,638
-2,748
| -0.4% | -$154K | 0.43% | 97 |
|
|
2022
Q3 | $32.5M | Sell |
767,386
-4,214
| -0.5% | -$179K | 0.36% | 122 |
|
|
2022
Q2 | $41.7M | Buy |
771,600
+25,892
| +3% | +$1.4M | 0.45% | 92 |
|
|
2022
Q1 | $47.9M | Buy |
745,708
+28,922
| +4% | +$1.86M | 0.43% | 93 |
|
|
2021
Q4 | $48M | Sell |
716,786
-6,023
| -0.8% | -$403K | 0.4% | 102 |
|
|
2021
Q3 | $49.5M | Sell |
722,809
-3,873
| -0.5% | -$265K | 0.44% | 83 |
|
|
2021
Q2 | $49.6M | Buy |
726,682
+991
| +0.1% | +$67.6K | 0.43% | 85 |
|
|
2021
Q1 | $50.1M | Buy |
725,691
+99,892
| +16% | +$6.9M | 0.46% | 76 |
|
|
2020
Q4 | $40.6M | Buy |
625,799
+1,697
| +0.3% | +$110K | 0.43% | 89 |
|
|
2020
Q3 | $29.5M | Buy |
624,102
+5,457
| +0.9% | +$258K | 0.39% | 106 |
|
|
2020
Q2 | $29.1M | Sell |
618,645
-18,222
| -3% | -$856K | 0.41% | 96 |
|
|
2020
Q1 | $28.4M | Buy |
636,867
+541,181
| +566% | +$24.2M | 0.5% | 72 |
|
|
2019
Q4 | $5.58M | Buy |
+95,686
| New | +$5.58M | 0.07% | 234 |
|